Recommended reading from A&R and AC&R
Search results for: cardiovascular disease
Science from our Sisters
Recommended reading from A&R and AC&R
Meet the Lumbar Spinal Stenosis Challenge
Limited evidence and diagnostic options make this increasing condition difficult to treat
NSAIDs: The Heart of the Controversy
Rheumatologists on the AHA statement and how to balance NSAID risks and benefits
REF Award Opens New Doors for Young Investigator
Do you know that old adage about the best-laid plans? If you ask Jon T. Giles, MD, about it, he’d agree that even the firmest plans change. “When I entered medical school at Vanderbilt University, I was convinced that I’d pursue subspecialty training in neurology,” recalls Dr. Giles. “My plan was to specialize in movement disorders.”
Have We Reached an Estrogen Comfort Zone?
A review of research on prescribing estrogens in systemic lupus erythematosus
Put Hughes Syndrome on Your Radar
Diagnosis of antiphospholipid syndrome is increasing. Here’s how to recognize and treat it
A Heart In Danger
Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis
Positive Week 12 Results for Rosnilimab in Patients with RA
Early study results demonstrate that rosnilimab may be safe and effective for patients with rheumatoid arthritis, reducing the signs and symptoms of RA by week 12 and achieving important primary and secondary study end points.
FDA Approves Upadacitinib for GCA
Supported by data in patients with new-onset and relapsing giant cell arteritis (GCA), the FDA approved upadacitinib for the treatment of adults with GCA.
- « Previous Page
- 1
- …
- 34
- 35
- 36
- 37
- 38
- …
- 64
- Next Page »